- Investing Ideas
- Hong Kong Pharmaceuticals & Biotech High Insider Buying
Hong Kong Pharmaceuticals & Biotech High Insider Buying
Results
21
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
21 companies
CSPC Pharmaceutical Group
Market Cap: HK$95.8b
An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.
1093
HK$8.38
7D
-4.4%
1Y
-16.7%
Akeso
Market Cap: HK$88.0b
A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.
9926
HK$95.50
7D
-0.2%
1Y
-44.2%
3SBio
Market Cap: HK$42.9b
An investment holding company, engages in the development, production, marketing, and sale of biopharmaceutical products in the People’s Republic of China, the United States, and internationally.
1530
HK$17.22
7D
-1.5%
1Y
-44.4%
Sunshine Lake Pharma
Market Cap: HK$21.1b
Engages in the research, development, manufacture, and sale of pharmaceutical products for the treatment of infectious diseases, chronic diseases, and oncology.
6887
HK$36.66
7D
-5.3%
1Y
-39.1%
Duality Biotherapeutics
Market Cap: HK$16.5b
A clinical-stage biopharmaceutical company, discovers and develops antibody-drug conjugate (ADC) therapeutics to treat cancer, autoimmune diseases, and others in China and internationally.
9606
HK$182.00
7D
-17.7%
1Y
-53.5%
Fujian Haixi Pharmaceuticals
Market Cap: HK$15.7b
Engages in research and development, production, and sale of pharmaceutical products in China.
2637
HK$199.80
7D
17.5%
1Y
n/a
HBM Holdings
Market Cap: HK$10.9b
A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.
2142
HK$12.61
7D
2.9%
1Y
33.2%
Everest Medicines
Market Cap: HK$9.1b
A biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.
1952
HK$25.94
7D
3.7%
1Y
-64.3%
Suzhou Ribo Life Science
Market Cap: HK$8.6b
Researches and develops novel therapeutics for the treatment of cardiovascular, metabolic, renal, and liver diseases in Chinese mainland and internationally.
6938
HK$50.60
7D
9.4%
1Y
n/a
Alphamab Oncology
Market Cap: HK$7.6b
A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biotherapeutics for cancer treatment in the People’s Republic of China.
9966
HK$7.90
7D
4.4%
1Y
-13.1%
CStone Pharmaceuticals
Market Cap: HK$7.6b
A biopharmaceutical company, researches and develops anti-cancer therapies to address the unmet medical needs of cancer patients in Mainland China and internationally.
2616
HK$4.76
7D
9.3%
1Y
-33.7%
Shanghai Haohai Biological Technology
Market Cap: HK$7.6b
Shanghai Haohai Biological Technology Co., Ltd.
6826
HK$16.48
7D
0.2%
1Y
-43.6%
Shanghai Bao Pharmaceuticals
Market Cap: HK$5.8b
A biotechnology company, engages in the research, development, and commercialization of pharmaceutical products in Mainland China.
2659
HK$17.70
7D
-4.2%
1Y
n/a
Edding Genor Group Holdings
Market Cap: HK$3.3b
Engages in the research, development, manufacturing, and distribution of biopharmaceutical products in China, the United States, and internationally.
6998
HK$1.68
7D
-1.8%
1Y
-57.1%
Laekna
Market Cap: HK$2.8b
An investing holding company, engages in the discovering, development, and commercialization of therapies for patients with cancer, metabolic diseases, and liver fibrosis worldwide.
2105
HK$6.60
7D
14.7%
1Y
-66.9%
ImmuneOnco Biopharmaceuticals (Shanghai)
Market Cap: HK$1.3b
A biotechnology company, engages in the research and development of immuno-oncology therapies in China and the United States.
1541
HK$3.00
7D
-3.2%
1Y
-72.7%
Kintor Pharmaceutical
Market Cap: HK$819.7m
A clinical-stage novel drug developer, focuses on developing small molecules and biologic drugs for dermatology and oncology.
9939
HK$1.66
7D
0%
1Y
-21.7%
JW (Cayman) Therapeutics
Market Cap: HK$667.7m
A clinical stage cell therapy company, engages in the research and development, manufacture, and marketing of cellular immunotherapy products in the People’s Republic of China.
2126
HK$1.65
7D
4.8%
1Y
-68.8%
Lee's Pharmaceutical Holdings
Market Cap: HK$635.9m
An investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally.
950
HK$1.08
7D
0%
1Y
-41.6%
3D Medicines
Market Cap: HK$530.0m
A biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products in the People’s Republic of China.
1244
HK$2.16
7D
-2.9%
1Y
-73.7%
Sirnaomics
Market Cap: HK$435.6m
An RNA therapeutics biopharmaceutical company, discovers and develops drugs for indications with medical needs in the People’s Republic of China.
2257
HK$4.00
7D
2.6%
1Y
-54.1%